Harmony Biosciences Holdings (HRMY) Gross Profit (2020 - 2026)

Harmony Biosciences Holdings' Gross Profit history runs 7 years deep, the most recent figure standing at $170.9 million for Q1 2026.

• In Q1 2026, Gross Profit rose 11.87% year-over-year to $170.9 million; the TTM figure through Mar 2026 stood at $688.2 million (up 17.95% YoY), while the FY2025 annual figure was $670.1 million, up 20.11% from the prior year.
• Gross Profit came in at $170.9 million for Q1 2026 at Harmony Biosciences Holdings, down from $175.2 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $179.8 million in Q3 2025 to a low of $70.6 million in Q1 2022.
• A 5-year average of $130.2 million and a median of $128.0 million in 2023 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit soared 44.12% in 2022 and increased 11.87% in 2026, its largest moves.
• Harmony Biosciences Holdings' Gross Profit stood at $101.4 million in 2022, then grew by 23.5% to $125.3 million in 2023, then advanced by 17.24% to $146.9 million in 2024, then increased by 19.32% to $175.2 million in 2025, then slipped by 2.49% to $170.9 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $170.9 million, $175.2 million, and $179.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison